Mercury Trade Links share price & results

Mercury Trade Links Ltd.

Results to
Jun 2026
Ownership as of
Mar 2026
Start an Inve Case

Company research is public. Sign in to keep your own companies, notes and cases.

Reported

The figures, each with its period

Each figure keeps its basis and period; nothing is filled in.

MetricValueChangeBasisPeriodNote
Revenue5.0 ₹ crore—Quarterly, as filedQuarter to Jun 2026Revenue from operations as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Operating margin-1181.0 %—Operating profit / revenueQuarter to Jun 2026For the quarter; a change is in percentage points.
Net profit-64.0 ₹ crore—Quarterly, as filedQuarter to Jun 2026Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown.
Return on equityUnavailable−5.4 ptsFY Mar 2026 vs FY Mar 2025Trailing twelve monthsTTM to Jun 2026Not in the analysed materials. No older figure is substituted.
Free cash flow margin0.00 %+52.2 ptsFY Mar 2026 vs FY Mar 2025Fiscal yearFY ending Mar 2026(Operating cash flow − fixed-asset purchases + disposals) ÷ revenue.
Revenue growth (YoY)28.57 %+115.0 ptsFY Mar 2026 vs FY Mar 2022Trailing twelve monthsTTM to Jun 2026Revenue change against the same period one year earlier.

Source: Inve data from filed results; ratios from the Screener-verified panel · to Jun 2026

Price

₹3.52 +2.03% · +₹0.07

Last close 13 Oct 2026 · NSE · INR

Performance −76.9% 1Y

₹5.0₹10.0₹15.0Oct 25Nov 25Jan 26Feb 26Apr 26May 26Jul 26Aug 26Oct 26

1Y: ₹15.27 on 10 Oct 2025 → ₹3.52. High ₹15.27 (10 Oct 2025), low ₹3.39 (9 Oct 2026).

Previous close
₹3.45
Market cap
₹8 Cr
52-week range
₹3.39 – ₹14.51
One year
−75.74%
Return on equity (FY ending Mar 2026)
0.00%

Overview

Symbol
NSE:MERCTRD
Exchange
NSE
Currency
INR

Your own record

Start an Inve Case for Mercury Trade Links Ltd.

Free account: one company. Everything above stays public.

Write why you follow Mercury Trade Links Ltd. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.